Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | Immunotherapy: changing the landscape of cancer treatment

Jean-Pascal Machiels • 8 Sep 2017
ESMO 2017
Head and Neck Cancer

Immunotherapy has had a significant impact in the treatment of cancer patients. Jean-Pascal Machiels, MD, PhD, from the Cliniques Universitaires Saint-Luc, Brussels, Belgium speaks to us at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain to explain the importance of this treatment. However, the use of immunotherapy also carries risks – Dr Machiels discusses what these are and why they need to be explained to a patient.

More from Jean-Pascal Machiels

1:52
ESMO 2022 highlights in head and neck cancer
Jean-Pascal Machiels • 11 Sep 2022
1:09
Management of locally advanced HNSCC with IO
Jean-Pascal Machiels • 11 Sep 2022
2:57
KEYNOTE-412: pembrolizumab with CRT vs placebo plus CRT for locally advanced HNSCC
Jean-Pascal Machiels • 11 Sep 2022
2:14
Innovative approaches to the treatment of head and neck cancer
Jean-Pascal Machiels • 8 Sep 2017

Related Videos

1:03
Challenges in implementing liquid biopsies for head and neck cancer
Mouadh Barbirou • 7 Apr 2024
2:43
Molecular profiling of tumor biomarkers in head and neck cancer
Mouadh Barbirou • 7 Apr 2024
1:40
The future of squamous cell carcinoma research at ESMO Asia 2023
Brian Henick • 6 Dec 2023
0:54
The role of immunotherapy in PD-L1 low advanced squamous cell carcinoma
Brian Henick • 6 Dec 2023
The content of VJOncology is intended for healthcare professionals